<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                            NIH Public Access <br />                             Author Manuscript <br />                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                            Published final edited form  <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             J Biol Chem. 2007 January 19; 282(3): 1670&#226;&#8364;&#8220;1678. doi:10.1074/jbc.M610500200. <br />  <br />  <br />  <br />                            Role Lte1p  Low Temperature Essential Protein Involved <br />                            Mitosis) Proprotein Processing Yeast Secretory <br />                            Pathway* <br />  <br />                            Xiang Zhao&#226;&#8364;&#161;,&#194;&#167;, Amy Y. Chang&#194;&#182;, Akio Toh-e||, Peter Arvan&#226;&#8364;&#161;,1 <br />                            &#226;&#8364;&#161; Division Metabolism, Endocrinology <span id='am-15' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-16' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-19' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span>amp</span>; Diabetes, University Michigan Medical School, Ann Arbor, <br />                            Michigan 48109 <br />                            &#194;&#167; Sue Golding Graduate Division, Albert Einstein College Medicine, Bronx, New York 10461 <br />                            &#194;&#182; Department Molecular, Cellular, Developmental Biology, University Michigan, Ann Arbor, <br />                            Michigan 48109 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            || Department Biological Science, University Tokyo, Hongo 7-3-1, Tokyo 113-0033, Japan <br />  <br />                            Abstract <br />                                 previously identified single gene disruptions Saccharomyces cerevisiae allow <br />                                 enhanced immunoreactive insulin secretion primarily defective Kex2p-mediated <br />                                 endoproteolytic processing. eis mutants disrupted established VPS (vacuolar protein sorting) <br />                                 genes, sixth, LTE1, Low Temperature (&lt;15 &#194;&#176;C) Essential gene encoding large protein                                 potential <span id='am-30' about='obo:IMR_0200319' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-31' property="oboInOwl:hasDbXref" content="KEGG:C00242" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:id" content="IMR:0200319" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="Guanine" datatype="xsd:string"></span>guanine</span> <span id='am-22' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-23' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-24' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-25' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>nucleotide</span> exchange (GEF) domains. Lte1p functions positive regulator                                 mitotic GTPase Tem1p, overexpression Tem1p suppresses low temperature mitotic defect <br />                                 lte1. sequence analysis, Tem1p highest similarity Vps21p (yeast homolog mammalian <br />                                 Rab5). Unlike TEM1, LTE1 restricted mitosis expressed cell cycle. <br />                                 Lte1p function interphase cells largely unknown. confirm eis phenotype lte1 <br />                                 mutant cells demonstrate defect proalpha factor processing rescued expression                                 length Lte1p C-terminally truncated Lte1p lacking GEF homology domain.                                 overexpression Tem1p 13 structurally related GTPases suppress secretory <br />                                 proprotein processing defect.  overexpression Vps21p selectively restores proprotein <br />                                 processing manner dependent active <span id='am-1' about='obo:IMR_0001354' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-2' property="oboInOwl:id" content="IMR:0001354" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-5' property="rdfs:label" content="GTP" datatype="xsd:string"></span><span id='am-6' property="oboInOwl:hasExactSynonym" content="guanosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasAlternativeId" content="IMR:0200086" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C00044" datatype="xsd:string"></span>GTP</span>-bound form GTPase. contrast, NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                 vps21 mutant produces synthetic defect lte1 proprotein processing, synthetic <br />                                 growth defect.  data underscore link mitotic regulator, Lte1p, protein <br />                                 processing trafficking secretory/endosomal  <br />  <br />                                              genetic screen previously performed yeast mutagenized random gene <br />                                              disruptions  insertion lacZ/LEU2) identify genetically engineered cells exhibiting <br />                                              enhanced immunoreactive insulin secretion (eis,2 derived integrated GAL1 promoter- <br />                                              driven insulin-containing fusion protein called ICFP, Ref. 1). ICFP comprised                                              leader propeptide yeast alpha-mating factor contiguous single chain insulin, <br />  <br />  <br />                             work supported National Institutes Health Grant DK48280 help Molecular Biology Core U- <br />                            M Diabetes Research Training Center (NIH DK20572). <br />                            1To correspondence addressed: Division Metabolism, Endocrinology &amp; Diabetes, 5560 MSRB2, University                            Michigan, 1500 E. Medical Ctr Dr., Ann Arbor MI 48109. Tel.: 734-936-5505; Fax: 734-936-6684; E-mail: parvan@umich.edu. <br />                            2The abbreviations used  eis, enhanced immunoreactive insulin secretion gene; GEF, guanine nucleotide exchange factor; vps, <br />                            vacuolar protein sorting gene; ICFP, insulin-containing fusion protein; lte, low temperature essential gene; mAb, monoclonal antibody; <br />                            CPY, carboxypeptidase Y. <br />                             Zhao et al.                                                                                               Page 2 <br />  <br />  <br />                                          separated Kex2p cleavage site. Cleavage Kex2p-processing site causes insulin                                          delivered ultimately vacuole manner requires specific insulin structural <br />                                          features (2). 90,000 transformants originally screened, independent gene <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          disruptions identified. eis mutants secrete slightly                                          dramatically increased amounts unprocessed ICFP,  kex2&#206;&#8221; mutant exhibited <br />                                          maximal immunoreactive insulin secretion (1). analysis, eis mutants <br />                                          vacuolar protein sorting mutants vps8, vps35, vps13, vps4, vps36,                                          affect protein trafficking impair protein processing Golgi &#226;&#8225;&#8224; endosomal <br />                                          (e.g. Ref. 3). outcome explained ability Kex2p                                          secretory protein processing enzymes  Ste13p Kex1p) function properly requires <br />                                          continuous recycling Golgi endosomal systems (4). <br />  <br />                                          article, report eis4 caused disruption gene known LTE1 (5). <br />                                          LTE1 low temperature essential gene product required &lt;13 &#194;&#176;C allow yeast cells <br />                                          advance spindle pole checkpoint mitosis, small GTPase <br />                                          Tem1p essential (6). Lte1p positive regulator Tem1p function (7) overexpression <br />                                          TEM1 rescues cold-sensitive growth arrest lte1 cells (8). Lte1p large, modular- <br />                                          appearing primary structure including small GEF homology domains embedded C-                                          N-terminal regions (9). Overexpression lte1-mini (truncated lack domains)                                          suppress cold-sensitive growth arrest lte1D cells, raising possibility Lte1p                                          GEF Tem1p (10);  analysis supports hypothesis GEF <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          function Lte1p activates Tem1p (11). Importantly, Tem1p expression                                          significant mitosis (telophase), Lte1p stably expressed cell cycle <br />                                          (12), suggesting possible roles Lte1p interphase cells. <br />  <br />                                          Beginning G1 &#226;&#8224;&#8217; S transition cell cycle, secretory pathway focuses bud <br />                                          site expands bud shall daughter cell (13). Lte1p localization                                           regulated phosphorylation, Ref. 9) normally confined buds growing secretory <br />                                          activity, virtue interactions plasma membrane-associated Ras2p <br />                                          (10) bound cell polarity proteins bud Kel1p                                          Kel2p (14).  surprising discover lte1 screen revealing secretory <br />                                          protein processing mutants. present study, sought confirm secretory protein <br />                                          processing defect lte1 mutant cells. present work highlights importance Lte1p <br />                                          C-terminal region  includes GEF domain) proprotein processing. report <br />                                          genetic interactions VPS21 (encoding yeast homolog mammalian Rab5) LTE1, <br />                                          suggesting new role Lte1p protein trafficking secretory/endosomal systems. <br />  <br />                               EXPERIMENTAL PROCEDURES <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Strains Media <br />                                          Standard yeast media genetic manipulations described (15). Strain L5145/MI316 <br />                                          expresses ICFP single chromosomal locus driven GAL1 promoter (1). Strain <br />                                          lte1773 eis4 mutant L5145/pMI316 displaying enhanced immunoreactive insulin <br />                                          secretion random mutagenesis screening (1). strains employed study, <br />                                          unless stated  isogenic W303 L3852 (Table 1). <br />  <br />                               Plasmids Molecular Biology <br />                                          pRSGLC TRP1-marked centromeric plasmid (pRS314, Ref. 16) bearing TDH3 <br />                                          promoter (17). pPD34 plasmid, previously described (8), carries ~9-kb yeast genomic <br />                                          DNA fragment includes entire LTE1 gene. pPD34, ~6.0 kb NcoI-SphI fragment <br />                                          containing LTE1 coding downstream sequences  lacking promoter) excised <br />                                          subcloned shuttle vector pSL1180. cDNA fragment encoding initiator methionine <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                Page 3 <br />  <br />  <br />                                           triple Myc tag fused frame directly start codon LTE1. ~4.5-kb <br />                                           fragment including coding sequence terminator excised SacI inserted <br />                                           appropriate orientation site pYES2 (InVitrogen) produce pYL9, 2-&#206;&#188; plasmid <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           marked URA3, GAL1 promoter controls expression triple Myc-LTE1. <br />                                           pYL9DEV created introducing TGA stop condon EcoRV site LTE1                                           produce C-terminally truncated lte11012 mutant. VPS21 coding sequence                                           amplified genomic DNA PCR using following primers: GGATCCTTATCTAAGC <br />                                            introduces BamHI site, underlined) GTCGACAGATCTATTTATC                                            introduces SalI site, underlined). TEM1 coding sequence amplified genomic <br />                                           DNA PCR using following primers: GGATCCATTAAATTGAGTTAAGC                                            introduces BamHI site, underlined) GTCGACTCATGTATTAACGCCC                                            introduces SalI site, underlined). pTVPS21 pTTEM1 constructed digesting <br />                                           PCR products BamH SalI followed subcloning respective sites                                           pRS-GLC. plasmids employed study described Table 2. <br />  <br />                                           single point mutant Vps21p-S21L using QuikChange Site-directed <br />                                           Mutagenesis kit (Stratagene, La Jolla, CA) plasmid-encoded wild-type VPS21                                           template pair primers: <br />                                           GGTGAGGCAGCAGTTGGTAAATTGTCAATAGTCCTAAGG                                           CCTTAGGACTATTGACAATTTACCAACTGCTGCTCACC. single point mutant <br />                                           Vps21p-Q66L kit employing <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           TGGGACACTGCTGGGCTAGAGAGATTTGCATCTTTAGCA                                           TGCTAAAGATGCAAATCTCTCTAGCCCAGCAGTGTCCCA mutagenic primers. <br />  <br />                               Filter Blot Assays <br />                                           assay secretion insulin-containing peptides, cell patches replica-plated                                           nitrocellulose filters placed plates containing 2% galactose sole carbon source. <br />                                           24&#226;&#8364;&#8220;40 h, filter washed processed immunoblotting guinea pig anti- <br />                                           insulin peroxidase-conjugated secondary antibody previously described (1). CPY <br />                                           secretion cells detected filter overlay overnight growth cells described <br />                                           (18) using mouse mAb anti-CPY (Molecular Probes, 1:4000 dilution) peroxidase- <br />                                           conjugated secondary antibody (Jackson ImmunoResearch, 1:10000 dilution). <br />  <br />                               Bioactive Alpha Factor Proalpha Factor Secretion <br />                                           Assay secretion bioactive alpha factor described (19). MAT&#206;&#177; cells (0.015 <br />                                           OD600/1.5 &#206;&#188;l) spotted lawn MATa bar1 cells (LM23&#226;&#8364;&#8220;3az; Ref. 20)                                           synthetic complete medium. 1&#226;&#8364;&#8220;2 days 30 &#194;&#176;C, halos surrounding patches cells                                           visualized placing plates directly scanner converting digital images. Halo areas <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           quantified using Image Quant v5.2 (Molecular Dynamics, ). <br />  <br />                                           examine secretion proalpha factor, cells grown mid-log phase synthetic <br />                                           complete medium methionine cysteine. Cells harvested resuspended                                           0.8 OD600/ml fresh medium 1 mg/ml bovine serum albumin. 500 &#206;&#188;Ci 35S amino <br />                                           acid mixture (Expre35S35S, PerkinElmer Life Sciences) added sample,                                           incubation continued 50 min room temperature shaking. Medium separated <br />                                           cells centrifugation 19,500 &#195;&#8212; g 5 min. SDS added medium final <br />                                           concentration 1%, samples boiled 3 min. Secretion alpha factor-containing <br />                                           peptides recovered immunoprecipitation RW1 rabbit polyclonal anti-alpha <br />                                           factor antibody (kind gift Dr. D. Shields, Albert Einstein College Medicine, Bronx, NY) <br />                                           analyzed SDS-15%-PAGE fluorography. <br />  <br />  <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                  Page 4 <br />  <br />  <br />                               Western Blot <br />                                            Steady-state levels mycLte1p, Ste3-Myc, Kex2p analyzed cell lysates prepared <br />                                            mid-log cultures vortexing glass beads, described previously (21). Sample <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            loading normalized lysate protein measured BCA protein assay (Pierce).                                            SDS-PAGE electrotransfer nitrocellulose, blots probed anti-Myc (rabbit <br />                                            polyclonal 14; Santa Cruz Biotechnology, , Santa Cruz, CA) anti-Kex2p (rabbit <br />                                            polyclonal M120D; gift Dr. R Fuller, University Michigan) peroxidase-conjugated <br />                                            secondary antibody (Jackson ImmunoResearch, 1:5000 dilution). Bands visualized                                            enhanced chemiluminescence (Amersham Biosciences). <br />  <br />                               Metabolic Labeling Immunoprecipitation CPY <br />                                            Metabolic labeling performed using cultures grown mid-log phase synthetic complete <br />                                            medium methionine cysteine. Cells resuspended 1 OD600/ml, labeled                                            Expre35S35S 0.1 mCi 1 OD600 cells 5 min room temperature, chased                                            presence 10 mM unlabeled methionine cysteine. various chase times, aliquots                                            placed ice presence 10 mM sodium azide. Lysates prepared resuspended <br />                                            radioimmune precipitation assay buffer (10 mM Tris, pH 7.5, 150 nM NaCl, 2 mM EDTA, <br />                                            1% Nonidet P-40, 1% deoxycholate, 0.1% SDS) immunoprecipitation 1 &#206;&#188;l mouse <br />                                            mAb anti-CPY protein G-Sepharose beads. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Endocytic Degradation Ste3p <br />                                            previously described (22), strains carrying pSL2015 (GAL-STE3-myc) grown mid- <br />                                            log phase synthetic complete medium containing 2% galactose sole carbon source                                            stimulate expression Ste3p-myc. time 0, glucose (3%) added arrest                                            Ste3-myc synthesis. indicated times glucose addition, cells harvested,                                            lysate prepared SDS-PAGE Western blotting anti-Myc antibody. <br />  <br />                               RESULTS <br />                               Identification eis4 lte1 <br />                                            insulin secretory phenotype eis4 mutant strong eis <br />                                            mutants proved vps mutants (1). sequencing genomic DNA adjacent lacZ <br />                                            insertion, eis4 mutant caused disruption LTE1. length Lte1p                                            1435 amino acids, residues 1292&#226;&#8364;&#8220;1315 critical CDC25 homology domain                                            thought guanine nucleotide exchange activity. lacZ/LEU2 insertion <br />                                            eis4 yielded possibility expression Lte1p gene product C-terminally truncated <br />                                            residue 783. test effect losing C-terminal region Lte1p protein <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                            processing secretory pathway, prepared plasmid vectors, bearing N- <br />                                            terminally Myc-tagged version Lte1p control GAL1 promoter. ultimately <br />                                            concentrated constructs, encoding length Lte1p second encoding                                            Lte1p1012 C-terminally truncated residue 1012. forms expressed                                            cells stable proteins detected Western blotting anti-Myc antibody (Fig. 1A),                                            functionality proteins tested (Fig. 1B, . <br />  <br />                                            Haploid yeast glucose, galactose, raffinose plates grow 13 &#194;&#176;C,                                            eis4 cells (lte1783, data shown) lte11012 cells exhibit significant low temperature growth <br />                                            phenotype regardless carbon source (middle sector, Fig. 2A). length mycLte1p                                            restore low temperature growth lte11012 cells galactose raffinose plates,                                            glucose plates mycLte1p expression remains repressed (left sector, Fig. 2A). Using <br />                                            serial dilution, length mycLte1p expression restored quantitatively normal growth                                            lte1&#206;&#8221; cells 13 &#194;&#176;C, mycLte11012 complement growth defect (Fig. <br />  <br />  <br />                                               J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                  Page 5 <br />  <br />  <br />                                           2B). Likewise, enhanced secretion exogenously expressed immunoreactive insulin                                           lte1783 cells complemented mycLte1p (Fig. 1B).  C-terminal truncation <br />                                           Lte1p supports low temperature growth normal handling insulin precursor, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           mycLte1p fully functional capacities (Figs. 1 2). <br />  <br />                               Defect Proalpha Factor Processing lte1 Mutant Cells <br />                                           test Lte1p influences processing endogenous secretory protein substrate,                                           checked ability lte11012 cells produce bioactive alpha mating factor, assessed                                           ability cause growth arrest cells opposite mating type (20). spotted                                           lawn Mata cells galactose plates 30 &#194;&#176;C, wild-type &#206;&#177; cells surrounded large <br />                                           halo growth-arrested Mata cells. contrast, lte1&#206;&#8221; cells exhibited decrease halo <br />                                           area (Fig. 3A) averaged 35% reduction numerous experiments. data suggest <br />                                           Lte1p assists production bioactive alpha factor processing insulin- <br />                                           containing fusion protein (1). Notably, substrates require cleavage Kex2p                                           maturation secretory pathway proalpha factor requires additional processing <br />                                           events generate bioactive alpha factor. <br />  <br />                                           number vps mutants impair Kex2p-mediated secretory proprotein cleavage                                           accelerated delivery Kex2p degradative compartment resulting decreased Kex2p <br />                                           levels, vps mutants subtly influence processing enzymes significant <br />                                           change Kex2p levels  vps8 (3) vps21  report)). NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           note steady state Kex2p levels significantly affected loss expression                                           Lte1p (Fig. 3B). small reproducible increase secretion unprocessed <br />                                           proalpha factor medium lte11012 mutant cells, comparable vps8 cells (Fig. <br />                                           3C).  comparison, Fig. 3, B C vps21 mutant cells exhibit proalpha <br />                                           factor secretion significant decrease Kex2p level, kex2&#206;&#8221; cells exhibit <br />                                           massive proalpha factor secretion undetectable Kex2p.) <br />  <br />                                           Lte1p exhibits positive regulation Tem1p, small GTPase essential mitosis <br />                                           (7), wished determine secretory protein processing defect lte1 cells                                           secondary alteration cell growth. check  examined                                           overexpression Tem1p suppress protein processing defect lte11012 cells.                                           shown Fig. 4B, overexpression Tem1p allowed lte1 cells grow like wild type 13 &#194;&#176; <br />                                           C, previously reported (8). Importantly,  Tem1p overexpression did suppress <br />                                           alpha factor secretion defect lte1 (Fig. 4A, left). data suggest impaired <br />                                           secretory protein processing lte1 cells secondary defect cell growth. <br />  <br />                               lte1 Mutant Cells Exhibit vps Phenotype <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           LTE1 known vacuolar protein sorting (VPS) gene (23), eis mutants <br />                                           known vps mutants (1), checked secretion CPY lte1 cells (Fig. 5A). Unlike <br />                                           established vps mutants (e.g. vps4 vps23), lte1 mutant cells exhibited augmented <br />                                           CPY secretion filter overlay assay (Fig. 5A). sensitive immunoprecipitation assay <br />                                           media bathing lte1 cells demonstrated inconsequential secretion newly synthesized <br />                                           CPY (Fig. 5B). considered possibility delayed delivery precursor CPY                                           endosomal/vacuolar frank CPY secretion lte1 cells. check  cells <br />                                           pulse-labeled 35S amino acids 5 min, washed, chased various times                                           30 &#194;&#176;C (Fig. 5C). 5 min chase, P1 form CPY  endoplasmic reticulum) <br />                                           predominated P2 (Golgi) mature (vacuolar) forms apparent. 10 min <br />                                           chase, majority newly synthesized CPY processed mature <br />                                           form 30 min chase, processing appeared complete. lte11012 mutant cells exhibit <br />                                           small alpha factor halo, delay appearance mature CPY, indicating                                           general protein trafficking endosomal substantially perturbed (Fig. <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                 Page 6 <br />  <br />  <br />                                           5C).  checked endocytic internalization degradation cell surface  <br />                                           factor receptor, Ste3p, using &#226;&#8364;&#339;GAL-shut &#226;&#8364;? assay (22). Specifically, expression Myc- <br />                                           tagged Ste3p GAL1 control shut addition glucose, vacuolar delivery NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           degradation pre-existing cell surface receptors followed Western blotting                                           anti-Myc. shown Fig. 6, Ste3p degraded lte11053 mutant cells normal kinetics. <br />                                            lte1 vps mutant, showing global defects endosomal trafficking. <br />  <br />                               Genetic Interactions LTE1 VPS21, Yeast Homolog Mammalian Rab 5 <br />                                           functioning positive regulator Tem1p, Lte1p physically <br />                                           associate Ras2p-GTP manner dependent C-terminal GEF-like domain                                           Lte1p (10). consider related GTPases involved secretory protein <br />                                           processing, BLASTp search yeast proteins performed using length Tem1p                                           query sequence, yielding list small GTPases shown Table 3. Overall sequence <br />                                           similarity highest Vps21p  yeast homolog mammalian Rab5),                                           conserved GTPase domain itself, high degree similarity GTPases listed. <br />                                           Plasmid vectors overexpressing yeast gene products shown Table 3                                           transformed Mat&#206;&#177; lte1 mutant cells test suppression alpha factor halo defect. <br />                                           noted  Tem1p overexpression restore normal alpha factor halo lte1 <br />                                           mutant cells (Fig. 4A),  overexpression Ras2p dozen <br />                                           GTPases listed lower portion Table 3 (data shown).  VPS21 <br />                                           overexpression, driven promoter high copy plasmid (Fig. 7A) NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           strong constitutive (TDH3) promoter centromeric plasmid  shown), rescue                                           alpha factor halo defect lte1 mutant cells. effect specific, overexpression                                           Vps21p increase halo wild-type yeast, restore halo defect                                           unrelated vps23 mutant (Fig. 7A). abnormally enhanced immunoreactive insulin <br />                                           secretion lte1 cells suppressed overexpression Vps21p (Fig. 7B). <br />  <br />                                           looked synthetic interaction vps21 lte1 mutants.   <br />                                           comparison plates, vps21 mutant cells alpha factor halo                                           smaller wild-type cells, lte1 vps21 double mutant clearly synthetic <br />                                           effect, alpha factor halo smaller mutant (Fig. 8A).                                           synthetic effect observed vps mutants tested; e.g. lte1 vps9 <br />                                            established GEF Vps21p GTPase, Ref. 24) showed additive inhibition (reduction) <br />                                           alpha halo (Fig. 8B). Notably, lte1 vps21 double mutant cells major decrease                                           steady state levels Kex2p (Fig. 3B), exhibit synthetic increase secretion <br />                                           unprocessed proalpha factor (Fig. 3C).  data support interaction VPS21                                           LTE1 secretory pro-protein processing. <br />  <br />                               VPS21 Genetically Interacts lte1 Mitosis Different Way Secretory <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Proprotein Processing <br />                                           Given specificity Tem1p GTPase mitotic spindle pole checkpoint,                                           reason expect overexpression Vps21p, rescues alpha factor halo defect                                           lte1 cells, impact low temperature growth lte1 mutant cells.                                           surprising discover VPS21 expressed promoter multicopy <br />                                           plasmid, lte11012 mutant cell growth longer arrested 13 &#194;&#176;C (Fig. 9A).                                            VPS21 expressed strong constitutive promoter centromeric plasmid, rescued <br />                                           growth lte1&#206;&#8221; cells comparably TEM1 expressed promoter (Fig. <br />                                           9B). <br />  <br />                                           explore interactions VPS21 lte1, used semipermissive low <br />                                           temperature 17 &#194;&#176;C examine growth vps21 lte1, vps21 lte1 double mutant cells. <br />                                           25 &#194;&#176;C, strains grew like VPS21 LTE1 wild type (Fig. 10A, left). 17 &#194;&#176;C, <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                               Page 7 <br />  <br />  <br />                                          mitotic blockade lte1 cells demonstrated partial growth defect, growth <br />                                          vps21 lte1 double mutant cells profoundly inhibited (Fig. 10B). Growth vps21 <br />                                          mutant inhibited conditions (Fig. 10B). data provide <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          good genetic evidence presence Vps21p, endogenous expression levels, <br />                                          limits mitotic defect lte1 mutant cells. contrast, shown Fig. 10C, vps9 did                                          exert appreciable growth phenotype combined lte1 mutant, suggesting                                          GEF activity Vps9p important Vps21p play role Lte1p function. <br />  <br />                                          distinguish suppressor effects Vps21p secretory protein processing defect                                          lte1 cells versus suppression low temperature growth arrest lte1, compared                                          effect overexpressing inactive (persistently <span id='am-9' about='obo:IMR_0001357' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-10' property="oboInOwl:id" content="IMR:0001357" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasDbXref" content="KEGG:C00035" datatype="xsd:string"></span><span id='am-12' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasAlternativeId" content="IMR:0200191" datatype="xsd:string"></span><span id='am-14' property="rdfs:label" content="GDP" datatype="xsd:string"></span>GDP</span>-bound) Vps21p-S21L mutant versus <br />                                          constitutively active (persistently GTP-bound) Vps21p-Q66L mutant. measured                                          Western blotting  shown), protein expression level recombinant Vps21p <br />                                          mutant identical, equivalent cells overexpressing wild-type Vps21p. <br />                                          Using strains, apparent rescue alpha factor halo defect lte11012 cells <br />                                          achieved overexpressing persistently GTP-bound Vps21p-Q66L mutant,                                          GDP-bound Vps21p-S21L mutant devoid activity (Fig. 11, left panel). <br />  <br />                                          contrast behavior, overexpressing persistently GDP-bound Vps21p-S21L <br />                                          mutant exhibited similar degree suppression growth arrest phenotype lte1 cells <br />                                          13 &#194;&#176;C overexpressing wild-type Vps21p constitutive active Vps21p-Q66L <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          mutant (Fig. 11, right panel). data strongly suggest differences VPS21-mediated <br />                                          suppression mutant phenotypes lte1 cells: suppression secretory protein processing <br />                                          defect specifically requires active GTP-bound Rab, rescue low temperature <br />                                          growth arrest does require GTP-loading overexpressed Vps21p. <br />  <br />                               DISCUSSION <br />                                          Lte1p low temperature essential gene product allows yeast cells advance                                          end mitosis regulated small GTPase Tem1p. debated CDC25 <br />                                          homology (GEF) domain contained C-terminal region Lte1p normally required                                          mitotic function (10) currently favored view (11). TEM1 originally <br />                                          discovered screen high copy suppressor genes rescue cold-sensitive growth arrest <br />                                          lte1 cells (8). Tem1p expression turned mitosis, acts essential <br />                                          controller mitotic exit network. timing Tem1p activation Lte1p occurs                                          spindle pole body migrates bud. Lte1p localization bud appears regulated <br />                                          interactions Ras2p (10), phosphorylation state (11), interactions cell <br />                                          polarity proteins (14).  Lte1p function S-phase largely unknown. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          identified lte1 eis4, screen yeast mutants exhibit enhanced insulin <br />                                          secretion defects secretory protein processing (1). eis group mutants <br />                                          appears work impairing recycling secretory protein processing enzymes (e.g. <br />                                          Kex2p, Ste13p, Kex1p) Golgi endosomal systems (1). study                                          confirm original observations eis4  hypothetically produces protein containing <br />                                          783 residues Lte1p). Specifically, demonstrate eis4 phenotype                                          complemented length mycLte1p (Fig. 1).  demonstrate proprotein <br />                                          processing defect lte1 mutant cells ranging complete null lte11012 mutant                                          lacks C-terminal GEF domain. truncation mutant exhibits classic low temperature <br />                                          growth arrest, conditions truncated Lte11012 protein stably expressed, <br />                                          rescue low temperature growth lte1&#206;&#8221; cells (Fig. 2). lte11012 mutant produces <br />                                          bioactive alpha factor judged reproducibly smaller alpha factor halo increase <br />                                          secretion unprocessed proalpha factor. data suggest C-terminal GEF <br />                                          domain Lte1p involved role secretory protein processing. phenotype  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                Page 8 <br />  <br />  <br />                                          mild, resulting significant change intracellular Kex2p level, comparable certain <br />                                          vps mutants (Fig. 3).  lte1 vps mutant, exhibiting defect                                          trafficking vacuolar carboxypeptidase Y (Fig. 5) defect endocytic internalization <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          degradation cell surface Ste3p (Fig. 6). results compatible growing list <br />                                          mutants trafficking genes affect Golgi-early endosomal trafficking secretory <br />                                          proprotein processing produce vps phenotype, tlg2  large extent, <br />                                          tlg1 (25), chc1 (26), inp53 (27,28)). intracellular site Vps21p function <br />                                          involves Golgi-early endosome trafficking (29), Lte1p facilitate Vps21p activity                                          site; lte1 considered candidate addition foregoing list mutants. <br />  <br />                                          S-phase, Lte1p unlikely work Tem1p activation Tem1p expression                                          limited phase cell cycle (12).  unlike low temperature growth <br />                                          defect, secretory protein processing phenotype lte1 rescued overexpression <br />                                          TEM1 (Fig. 4). argue multicopy expression (Fig. 4), TEM1                                          suppress alpha factor halo defect lte1 mutant cells cell cycle-dependent <br />                                          regulation limits Tem1p availability.  TEM1 promoter replaced                                          strong constitutive TDH3 promoter, TDH3-TEM1 rescue alpha factor halo <br />                                          defect lte1 cells  shown).  overexpression Ras2p, Ras1p, 11 <br />                                          GTPases effect secretory protein processing (Table 3), suggesting Lte1p <br />                                          unlikely work GTPases secretory protein processing. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          contrast, VPS21, overexpressed lte1 mutant cells, restored production bioactive <br />                                          alpha mating factor  measured halo assay) restored normal                                          immunoreactive insulin secretion (Fig. 7). effect quite specific, insofar VPS21 <br />                                          overexpression increase secretory protein processing wild-type yeast vps <br />                                          mutants bearing unrelated genetic defects (Fig. 7).  vps21&#206;&#8221; exhibited synthetic <br />                                          defect secretory protein processing lte1, synthetic defect                                          mimicked deletion particular Vps21p GEF, vps9 (Fig. 8). results provide genetic <br />                                          evidence LTE1 interacts VPS21 manner independent VPS9. (Intriguingly <br />                                          lte1 mutant cells, synthetic defect exhibited vps21&#206;&#8221; mimicked                                          vps mutants tested, including vps4, vps23, pep12  shown), implying activity <br />                                          recycling proprotein processing enzymes endosomal )                                          explanations possible, simple hypothesis Lte1p function GEF <br />                                          Vps21p endocytic secretory subcompartment cells S-phase. <br />                                          Certainly rapidly expanding number potential GEFs identified appear <br />                                          support Vps21p GTPase mammalian homolog, Rab 5 (24). <br />  <br />                                          finding surprising  believe, quite distinct described                                           overexpression VPS21, previously implicated mitosis, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          rescued low temperature growth lte1 mutant cells (Fig. 9). true                                          lte1&#206;&#8221; cells cells bearing lte11012 truncation. Furthermore, vps21&#206;&#8221; exhibited                                          synthetic growth defect lte1 17 &#194;&#176;C, genetic interaction lte1 mitosis                                          mimicked merely cutting VPS9-mediated GEF activity Vps21p (Fig. 10).                                          propose unusual mitotic effects derive structural similarities                                          Vps21p Tem1p (Table 3). reason believe Vps21p plays                                          specific role mitosis, hypothesize Vps21p compete certain interaction <br />                                          partners, GAP (GTPase-activating) proteins tonically inhibit Tem1p                                          converting protein active GTP-bound form inactive GDP-bound form.                                          recruitment proteins Vps21p increase activity Tem1p, <br />                                          facilitating low temperature mitotic progression lte1 background. Alternatively, VPS21 <br />                                          activity endosomal trafficking theoretically facilitate localization                                          anchoring proteins regulators mitotic exit network, enhancing Tem1p <br />                                          activation spindle pole body checkpoint.  favor hypothesis <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                               Page 9 <br />  <br />  <br />                                          rescue low temperature growth lte1 mutant cells achieved                                          overexpressing inactive, persistently GDP-bound, Vps21p-S21L mutant (Fig. 11). <br />                                          Altogether, findings underscore secretory protein processing defect lte1 mutant cells, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          rescue specifically requires overexpressing active Vps21p achieve                                          GTP-bound state (Fig. 11). <br />  <br />                               Acknowledgements <br />                                          thank members Arvan Chang laboratories helpful discussions. <br />  <br />  <br />                               References <br />                                          1. Zhang, B-y; Chang, ; Kjeldsen, TB.; Arvan, P. J Cell Biol 2001;153:1187&#226;&#8364;&#8220;1197. [PubMed: <br />                                              11402063] <br />                                          2. Zhang, B-y; Liu, M.; Arvan, P. J Biol Chem 2003;278:3687&#226;&#8364;&#8220;3693. [PubMed: 12446709] <br />                                          3. Luo W, Chang  J Cell Biol 1997;138:731&#226;&#8364;&#8220;746. [PubMed: 9265642] <br />                                          4. Johnston HD, Foote C, Santeford  Nothwehr SF. Mol Biol Cell 2005;16:1456&#226;&#8364;&#8220;1468. [PubMed: <br />                                              15647379] <br />                                          5. Wickner RB, Koh TJ, Crowley JC, O&#226;&#8364;&#8482;Neil J, Kaback DB. Yeast 1987;3:51&#226;&#8364;&#8220;57. [PubMed: 3332963] <br />                                          6. Molk JN, Schuyler SC, Liu JY, Evans JG, Salmon ED, Pellman D, Bloom K. Mol Biol Cell <br />                                              2004;15:1519&#226;&#8364;&#8220;1532. [PubMed: 14718561] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          7. Jensen S, Johnson AL, Johnston LH, Segal M. Cell Cycle 2004;3:817&#226;&#8364;&#8220;822. [PubMed: 15197338] <br />                                          8. Shirayama M, Matsui Y, Toh-e  Yeast 1994;10:451&#226;&#8364;&#8220;461. [PubMed: 7941731] <br />                                          9. Jensen S, Geymonat M, Johnson AL, Segal M, Johnston LH. J Cell Sci 2002;115:4977&#226;&#8364;&#8220;4991. [PubMed: <br />                                              12432084] <br />                                          10. Yoshida S, Ichihashi R, Toh-e  J Cell Biol 2003;161:889&#226;&#8364;&#8220;897. [PubMed: 12782684] <br />                                          11. Seshan  Amon  Cell Cycle 2005;4:940&#226;&#8364;&#8220;946. [PubMed: 15917658] <br />                                          12. Bardin AJ, Visintin R, Amon  Cell 2000;102:21&#226;&#8364;&#8220;31. [PubMed: 10929710] <br />                                          13. Lord M, Yang MC, Mischke M, Chant J. J Cell Biol 2000;151:1501&#226;&#8364;&#8220;1512. [PubMed: 11134078] <br />                                          14. Hofken T, Schiebel E. EMBO J 2002;21:4851&#226;&#8364;&#8220;4862. [PubMed: 12234925] <br />                                          15. Sherman, F.; Hicks, JB.; Fink, GR. Laboratory Manual. Cold Spring Harbor Laboratory Press; <br />                                               Cold Spring Harbor, NY: 1986. <br />                                          16. Sikorski RS, Hieter P. Genetics 1989;122:19&#226;&#8364;&#8220;27. [PubMed: 2659436] <br />                                          17. Warner JR. Methods Enzymol 1991;194:423&#226;&#8364;&#8220;428. [PubMed: 2005801] <br />                                          18. Roberts CJ, Raymond CK, Yamashiro CT, Stevens TH. Methods Enzymol 1991;194:644&#226;&#8364;&#8220;661. <br />                                               [PubMed: 1706462] <br />                                          19. Sprague GFJ. Methods Enzymol 1991;194:77&#226;&#8364;&#8220;93. [PubMed: 2005823] <br />                                          20. Marsh L. Mol Cell Biol 1992;12:3959&#226;&#8364;&#8220;3966. [PubMed: 1324410] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          21. Chang  Slayman CW. J Cell Biol 1991;115:289&#226;&#8364;&#8220;295. [PubMed: 1833410] <br />                                          22. Davis ND, Horecka JL, Sprague GFJ. J Cell Biol 1993;122:53&#226;&#8364;&#8220;65. [PubMed: 8391002] <br />                                          23. Bonangelino CJ, Chavez EM, Bonifacino JS. Mol Biol Cell 2002;13:2486&#226;&#8364;&#8220;2501. [PubMed: <br />                                               12134085] <br />                                          24. Carney DS, Davies BA, Horazdovsky BF. Trends Cell Biol 2006;16:27&#226;&#8364;&#8220;35. [PubMed: 16330212] <br />                                          25. Holthuis JC, Nichols BJ, Dhruvakumar S, Pelham HR. EMBO J 1998;17:113&#226;&#8364;&#8220;126. [PubMed: <br />                                               9427746] <br />                                          26. Yeung BG, Phan HL, Payne GS. Mol Biol Cell 1999;10:3643&#226;&#8364;&#8220;3659. [PubMed: 10564262] <br />                                          27. Bensen ES, Costaguta G, Payne GS. Genetics 2000;154:83&#226;&#8364;&#8220;97. [PubMed: 10628971] <br />                                          28. Ha SA, Torabinejad J, DeWald DB, Wenk MR, Lucast L, Camilli P, Newitt RA, Aebersold R, <br />                                               Nothwehr SF. Mol Biol Cell 2003;14:1319&#226;&#8364;&#8220;1333. [PubMed: 12686590] <br />                                          29. Singer-Kruger B, Stenmark H, Zerial M. J Cell Sci 1995;108:3509&#226;&#8364;&#8220;3521. [PubMed: 8586662] <br />                                          30. Thomas BJ, Rothstein R. Cell 1989;56:619&#226;&#8364;&#8220;630. [PubMed: 2645056] <br />  <br />  <br />  <br />                                              J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                                 Page 10 <br />  <br />  <br />                                          31. Singer-Kruger B, Stenmark H, Dusterhoft  Philippsen P, Yoo JS, Gallwitz D, Zerial M. J Cell Biol <br />                                              1994;125:283&#226;&#8364;&#8220;298. [PubMed: 8163546] <br />                                          32. Walworth NC, Brennwald P, Kabcenell AK, Garrett M, Novick P. Mol Cell Biol 1992;12:2017&#226;&#8364;&#8220;2028. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              [PubMed: 1569938] <br />                                          33. Jedd G, Mulholland J, Segev N. J Cell Biol 1997;137:563&#226;&#8364;&#8220;580. [PubMed: 9151665] <br />                                          34. Ohya Y, Qadota H, Anraku Y, Pringle JR, Botstein D. Mol Biol Cell 1993;4:1017&#226;&#8364;&#8220;1025. [PubMed: <br />                                              8298188] <br />                                          35. Matsui Y, Toh-E  Mol Cell Biol 1992;12:5690&#226;&#8364;&#8220;5699. [PubMed: 1448099] <br />                                          36. Powers S, Kataoka T, Fasano O, Goldfarb M, Strathern J, Broach J, Wigler M. Cell 1984;36:607&#226;&#8364;&#8220; <br />                                              612. [PubMed: 6365329] <br />                                          37. Li B, Warner JR. J Biol Chem 1996;271:16813&#226;&#8364;&#8220;16819. [PubMed: 8663225] <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                             Page 11 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 1. Expression Myc-tagged Lte1p functionality length construct                                          restoring normal cellular handling insulin-containing fusion protein <br />                                           cells grown liquid medium 2% raffinose  allow expression GAL1 <br />                                          promoter) lysed analyzed expression length mycLte1p mycLte11012                                          Western blot, normalized equal total cell protein. Molecular mass estimated mobility <br />                                          molecular weight markers shown right. B, filter blot assay immunoreactive insulin <br />                                          secretion plates containing 2% galactose. lte1 mutant shown figure eis4 <br />                                          mutant described previously (1) insertional mutagenesis results Lte1p truncated <br />                                          773 residues. eis mutants impair proprotein processing, resulting enhanced <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                        Page 12 <br />  <br />  <br />                                          immunoreactive insulin secretion (1), expression length mycLte1p restores                                          insulin secretion levels seen wild-type (wt) cells. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                             Page 13 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 2. Low temperature growth defect lte11012 lte1 null (lte1&#206;&#8221;) cells rescued                                          expression mycLte1p <br />                                           wild-type (wt) lte11012 cells transformed pYES2 high copy <br />                                          expression plasmid; lte11012 mutant cells grow efficiently 13 &#194;&#176;C carbon <br />                                          source.  lte11012 cells expressing mycLte1p GAL1 promoter pYES2 grew <br />                                          normally galactose  GAL1 promoter strongly stimulated) raffinose                                           GAL1 promoter strongly stimulated). B, quantitative growth assay galactose <br />                                          plates wild-type (wt) yeast growth compared lte1&#206;&#8221; yeast, lte1&#206;&#8221; bearing <br />                                          length mycLte1p  line) mycLte1p1012  line). line contains identical <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 14 <br />  <br />  <br />                                          volume yeast starting identical OD, spotted sequential 10-fold serial dilutions                                          left right. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                             Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 3. Defective production biologically active alpha mating factor lte1 cells <br />                                           alpha factor halo lawn cells LM23&#226;&#8364;&#8220;3a (MATa bar1). lte1&#206;&#8221; cells exhibit                                          37.7 &#194;&#177; 1.8% reduction alpha factor halo area. experiment reproduced                                          replicates independent experiments. B, Western blot steady state Kex2p levels, <br />                                          normalized total cellular protein, lte11012 mutant cells, vps21&#206;&#8221; cells, lte11012 vps21&#206;&#8221; <br />                                          double mutant cells. result kex2&#206;&#8221; strain provided negative control, left. <br />                                          C, secretion immunoreactive alpha factor strains shown B, vps8 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          cells. strain grown mid-log phase. Identical OD units cells labeled <br />                                          35S amino acids described &#226;&#8364;&#339;Experimental Procedures,&#226;&#8364;? medium collected. <br />                                          Immunoprecipitates medium anti-alpha factor antibody analyzed                                          SDS-PAGE fluorography. background band seen wild-type (wt) cells just                                          proalpha factor migration position. kex2&#206;&#8221; strain analyzed right; presence <br />                                          high molecular mass proalpha factor band indicates deficiency Kex2p activity.                                          secretory protein processing activities deficient vps mutant strains.                                          appearance band gel comigrates mature alpha factor                                          useful control total proalpha factor expression strains, does                                          mean material biologically active, additional Kex2p, Ste13p, Kex1p <br />                                          cleavages required produce bioactive alpha factor low molecular mass <br />                                          inactive intermediates (23) resolved dye SDS-PAGE <br />                                          conditions shown  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                              Page 16 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 4. High copy TEM1 expression (8) lte11012 cells: effects secretory protein processing <br />                                          low temperature growth <br />                                           alpha factor halo assay (cells grown 30 &#194;&#176;C). alpha factor halo area 64.2 &#194;&#177; 9.4% <br />                                          lte11012 cells 48.2 &#194;&#177; 1.5% lte11012 cells high copy expression TEM1. B, <br />                                          growth 13 &#194;&#176;C. Note TEM1 overexpression rescues low temperature growth,                                          induce recovery production bioactive alpha factor. <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 5. Lack vps phenotype lte11012 mutant cells <br />                                           filter overlay immunoreactive CPY secretion selected strains (vps4 vps23 shown <br />                                          positive controls; wild-type yeast (WT) negative control). B, 30 min continuous <br />                                          labeling indicated strains 35S amino acids, followed immunoprecipitation NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          labeled cells media anti-CPY antibody. immunoprecipitates analyzed                                          SDS-PAGE phosphorimaging. vps21 cells secrete CPY precursor, sorting                                          CPY lte1 mutant cells appears similar wild-type yeast (WT). C, 25 &#194;&#176;C, wild-type <br />                                          (LTE1) mutant (lte11012) cells labeled 5 min 35S amino acids chased <br />                                          number minutes indicated panel. Cell lysates prepared                                          immunoprecipitated anti-CPY antibody, analyzed SDS-PAGE                                          fluorography demonstrate intracellular maturation kinetics CPY precursor. positions <br />                                          endoplasmic reticulum P1 form, Golgi P2 form, vacuolar mature form CPY                                          indicated, right. <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 18 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 6. Endocytic degradation Ste3p <br />                                          Wildtype (WT) lte111012 strains transformed pSL2015 (GAL1-STE3-myc). <br />                                          Endocytic degradation Ste3p-Myc analyzed described &#226;&#8364;&#339;Experimental <br />                                          Procedures.&#226;&#8364;? times indicated, aliquot yeast removed analyzed <br />                                          Western blot. Time 0 represents steady-state level Ste3 addition glucose <br />                                          final concentration 3%. blot probed anti-Myc; position Myc-tagged <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          Ste3p indicated left. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                              Page 19 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 7. Overexpression VPS21 rescues secretory protein processing defect lte11012 <br />                                          mutant cells <br />                                           wild-type (wt) cells lte11012 cells transformed plasmid pYPT51. alpha <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          factor halo defect lte1 mutant cells (52.5% wild-type cells) selectively rescued <br />                                           95.3%) overexpression VPS21  small GTPases listed Table <br />                                          3). Note VPS21 overexpression did enlarge normal halo wild-type cells, <br />                                          did normalize small halo unrelated (vps23) mutant. B, filter blot                                          immunoreactive insulin wild-type (wt) lte1773 (eis4) mutant cells transformed                                          vector, multicopy VPS21. Note abnormally eis phenotype lte1 mutant cells                                          improved (diminished) overexpression VPS21. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 20 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 8. Synthetic effects lte11012 vps21&#206;&#8221; double mutant lte11012 vps9 double mutant <br />                                           wild-type yeast (WT) mutant MAT&#206;&#177; tester strains indicated spotted                                          lawn LM23-3a (MATabar1) cells duplicate single plate. results shown                                          replicated independent experiments. Note single lte1 vps21 mutants <br />                                          modest deficiencies bioactive alpha factor production; lte1 vps21 double mutant <br />                                          exhibited major reduction halo size (28.3 &#194;&#177; 11.3% wild-type cells), indicating                                          synthetic defect. B,  combining lte1 vps9 mutants.                                          single vps9 mutant small halo, inhibitory effects production bioactive alpha <br />                                          factor additive inhibitory effect lte1 mutant. <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                            Page 21 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 9. Overexpression VPS21 rescues low temperature growth defect lte11012 mutant <br />                                          cells <br />                                           growth 13 &#194;&#176;C lte11012 cells transformed vector (right sector) high <br />                                          copy plasmid bearing VPS21 (pYPT51, left sector); strain grows like wild-type yeast <br />                                          (WT). B, growth 13 &#194;&#176;C wild-type (wt) lte11012 cells transformed pRS314 <br />                                          (CEN) vector pRS314 bearing TDH3-VPS21 (pTVPS21) TDH3-TEM1(pTTEM1). <br />                                          conditions, overexpression VPS21 restores normal growth lte11012 cells equal <br />                                          rescue provided TEM1. <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                         Page 22 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 10. Synthetic growth defect vps21 lte11012 <br />                                           quantitative growth assay wild-type (VPS21 LTE1), lte1 mutant (VPS21 lte11012), <br />                                          vps21&#206;&#8221; (vps21&#206;&#8221; LTE1), double mutant (vps21&#206;&#8221; lte11012) cells 25 &#194;&#176;C. B, growth                                          strains 17 &#194;&#176;C. C, quantitative growth assay wild-type (VPS9 LTE1), lte1 mutant <br />                                          (VPS9 lte11012), vps9&#206;&#8221; (vps9&#206;&#8221; LTE1), double mutant (vps9&#206;&#8221; lte11012) cells 17 &#194;&#176;C.                                          row contains identical volume yeast starting identical OD, pipetted sequential <br />                                          10-fold serial dilution left right. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                             Zhao et al.                                                                                           Page 23 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                          FIGURE 11. Function constitutively active GTP-bound mutant form Vps21p (Vps21p-Q66L) <br />                                          persistently GDP-bound mutant form Vps21p (Vps21p-S21L) rescue secretory <br />                                          protein processing low temperature growth defects lte11012 mutant cells <br />                                          Overexpression Vps21p mutant forms Vps21p accomplished Fig. 9B. Left <br />                                          panel, alpha factor halo assay. Right panel, quantitative growth assay strains                                          13 &#194;&#176;C. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                                    Zhao et al.                                                                                                       Page 24 <br />  <br />                                                                                      TABLE 1 <br />                            Yeast strains used study <br />  <br />                               Strains                         Genotype                                                                       Source <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               W303                            MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52                           30 <br />                               L3852                           MAT&#206;&#177; his3-200 lys2-201 leu2-3,112 ura3-52 ade2                                    3 <br />                               L5145                           Mata kss1 ura3-52 leu2-3,112 his3 trp1&#204;&#8218;63 ade2 GAL+                               3 <br />                               L4                              MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte11012::URA3        study <br />                               H4                              MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte11012::HIS3        study <br />                               lte1&#206;&#8221;                           MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte1&#206;&#8221;::HIS3           study <br />                               vps23&#206;&#8221;                          MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 vps23&#206;&#8221;::TRP1          study <br />                               vps8&#206;&#8221;                           MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 vps8&#206;&#8221;::URA3           study <br />                               VPS21 lte11012                  MAT&#206;&#177; his3-200 lys2-201 leu2-3,112 ura3-52 ade2 lte11012::URA3                studya <br />                               vps21&#206;&#8221; LTE1                     MAT&#206;&#177; his3-200 lys-201 ura3-52 leu2-3,112 ade2 vps21&#206;&#8221;::LYS2                   studya <br />                               vps21&#206;&#8221; lte11012                 MAT&#206;&#177; his3-200 lys2-201 leu2-3,112 ura3-52 ade2 vps21&#206;&#8221;::LYS2 lte11012::URA3   studya <br />                               vps9&#206;&#8221;                           MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 vps9&#206;&#8221;::HIS3           study <br />                               vps9&#206;&#8221; lte11012                  MAT&#206;&#177; ade2-1 can1-100 his3-11 leu2-3,112 trp1-1 ura3-52 lte11012::URA3        study <br />                                                               vps9&#206;&#8221;::HIS3 <br />                               BFY106-4D                       MAT&#206;&#177; ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 kex2&#206;&#8221;::HIS3            3 <br />                               LM23-3az                        MATa bar1 ura3 leu2 his4 trp1 met1 [FUS1-lacZ::URA3]                             20 <br />  <br />                                                              L3852L4, vps21&#206;&#8221;, vps21&#206;&#8221; lte11012 isogenic L3852. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                             J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                                  Zhao et al.                                                                                                           Page 25 <br />  <br />                                                                                    TABLE 2 <br />                            Plasmids used study <br />  <br />                              Plasmid                                 Description                                                           Source <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                              pSL2015                                 CEN URA3 GAL-STE3-myc YCp50                                           22 <br />                              pYpt51                                  2&#206;&#188; URA3 VPS21 pSEY8                                                   31 <br />                              pYpt52                                  2&#206;&#188; LEU2 YPT52 YEp13                                                   31 <br />                              pYPT53                                  2&#206;&#188; URA3 YPT53 pSEY8                                                   31 <br />                              pYEplac181-TEM1                         2&#206;&#188; LEU2 TEM1 YEplac181                                                 8 <br />                              pBB80                                   2&#206;&#188; URA3 SEC4 YEp24                                                    32 <br />                              pAC77                                   2&#206;&#188; LEU2 YPT7                                               Chang collection, U. Michigan <br />                              pNS455                                  2&#206;&#188; URA3 GAL-YPT32 YEp352                                              33 <br />                              pNS198                                  2&#206;&#188; URA3 GAL-YPT31 YEp24                                               33 <br />                              pRB1594                                 2&#206;&#188; LEU2 CDC42 Yep351                                                  34 <br />                              pRB1596                                 2&#206;&#188; TRP1 RHO2 pYO324                                                   34 <br />                              pRB1592                                 2&#206;&#188; TRP1 RHO1 pYO324                                                   34 <br />                              pYO324-RHO4                             2&#206;&#188; TRP1 RHO4 pYO324                                                   35 <br />                              YEpRas1                                 2&#206;&#188; LEU2 RAS1                                                             36 <br />                              YEpRas2                                 2&#206;&#188; LEU2 RAS2                                                             36 <br />                              pYPT6                                   CEN URA3 YPT6 YIp5                                                    37 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                                          J Biol Chem. Author manuscript; available PMC 2008 September 10. <br />                                   Zhao et al.                                                                                                       Page 26 <br />  <br />                                                                                        TABLE 3 <br />                            Small GTPases similarity Tem1p tested suppression protein processing defect lte1 mutant cells <br />  <br />                              GTPase                          % Overall similarity        Type plasmida                     Vector used expression <br />                          <br /> </body></html>